Clinical Trials Browser

Phase 1 × Glioma × Blood Component Removal × Clear all

NCT06964737 2025-10-29

Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas

Phase 1 Recruiting

Glioma

NCT01808820 2022-07-20

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Phase 1 Completed

Astrocytoma, Glioblastoma, Glioma

NCT01902771 2017-03-10

Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors

Phase 1 Terminated

Brain Neoplasms, Glioblastoma, Glioma